![Jörn Aldag](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörn Aldag
Keine laufenden Positionen mehr
Vermögen: 75 042 $ am 31.05.2026
Profil
Jörn Aldag is the founder of G7 Therapeutics AG, founded in 2013.
Current jobs include Chairman at GenAspire Srl, Non-Executive Director at Idorsia Pharmaceuticals Ltd. since 2020, and Member-Supervisory Board at DESERTEC Foundation since 2010.
Former jobs include President & Chief Executive Officer at Evotec SE from 1997 to 2008, Chief Executive Officer at Amsterdam Molecular Therapeutics (AMT).
Holding NV from 2009 to 2015, Chief Executive Officer at uniQure NV from 2009 to 2015, Chief Executive Officer at Hookipa Biotech AG, Chief Executive Officer & Director at HOOKIPA Pharma, Inc. from 2017 to 2024, Chairman at Molecular Partners AG from 2007 to 2018, Independent Director at Cogent Biosciences, Inc. from 2016 to 2020, Finance Director & Vice President at MAN Gutehoffnungshutte AG, and Director-Business Development at Treuhandanstalt.
Education includes an undergraduate degree from Harvard Business School, conferred in 1994.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2024 | 11’694 ( 0% ) | 66 840 $ | 31.05.2026 | |
HOOKIPA PHARMA INC. 0.07% | 04.06.2025 | 7’195 ( 0.07% ) | 8 202 $ | 31.05.2026 |
Aktive Positionen von Jörn Aldag
| Unternehmen | Position | Beginn |
|---|---|---|
DESERTEC Foundation | Direktor/Vorstandsmitglied | 23.06.2010 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Direktor/Vorstandsmitglied | 13.05.2020 |
Ehemalige bekannte Positionen von Jörn Aldag
| Unternehmen | Position | Ende |
|---|---|---|
| HOOA PHARPAR | Vorstandsvorsitzender | 22.07.2024 |
| IDORSIA LTD | Direktor/Vorstandsmitglied | 13.06.2024 |
| COGENT BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.07.2020 |
| MOLECULAR PARTNERS AG | Vorsitzender | 18.04.2018 |
G7 Therapeutics AG
 G7 Therapeutics AG Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Gründer | 01.01.2016 |
Ausbildung von Jörn Aldag
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
93
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
MAN Gutehoffnungshutte AG
 MAN Gutehoffnungshutte AG Wholesale DistributorsDistribution Services Supplies automobile parts | Distribution Services |
Treuhandanstalt
 Treuhandanstalt Finance/Rental/LeasingFinance Project finance | Finance |
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Commercial Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
DESERTEC Foundation | |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Health Technology |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G7 Therapeutics AG
G7 Therapeutics AG Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Health Technology |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Wählen Sie MarketScreener 
